Clinical Trials Directory

Trials / Unknown

UnknownNCT05938985

Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI)

Psychometric Properties of the Croatian Version of the Ocular Surface Disease Index Questionnaire

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University Hospital Sestre Milosrdnice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Ocular Surface Disease Index (OSDI) Questionnaire is an important tool for the diagnosis of dry eye disease. Croatian version is yet not available. With a permission of AbbVie company investigators want to make a Croatian version of the Ocular Surface Disease Index Questionnaire (Cro-OSDI).

Detailed description

Aim is to translate, adapt and validate the Croatian version of the Ocular Surface Disease Index (OSDI) Questionnaire. Validation process of the Croatian version of the OSDI questionnaire will be accomplished in two phases: the translation and assessment of psychometric properties. The translation process will involve the following steps based on the previously established guidelines. First is forward translation, the second is backward translation and the third is pilot study. The final version (the Cro-OSDI) will be used to test psychometric properties of the Croatian version of the questionnaire. Eligible participants will complete the Cro-OSDI and and the previously validated Croatian version of the National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25). After completing the respective questionnaires, the participants will undergo a complete ophthalmic examination for both eyes and dry eye tests (corneal fluorescein staining, lissamine green staining, Schirmer test type I and II, tear break-up time (TBUT), noninvasive tear breakup time (NIBUT)).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTQuestionnaires and dry eye testsOcular Surface Disease Index (OSDI), National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25), best visual acuity (BCVA) measuring, intraocular pressure, corneal fluorescein staining, lissamine green staining, Schirmer test type I and II, tear breakup time (TBUT) and noninvasive tear breakup time (NIBUT).

Timeline

Start date
2023-06-12
Primary completion
2023-10-31
Completion
2023-11-02
First posted
2023-07-11
Last updated
2023-07-11

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT05938985. Inclusion in this directory is not an endorsement.